Physician

James Matthew Brennan, M.D.

According to 2025 Medicare claims, James Brennan, M.D. (NPI: 1164689105) practices cardiology in the Durham-Chapel Hill, NC market, with the plurality of this provider's patient population coming from Durham, NC. This provider's primary affiliated billing organization is DUKE HEALTH INTEGRATED PRACTICE, INC. (NPI: 1205553369; TIN: 862109896) and primary practice location at 27705-2671. Brennan is affiliated with the Duke Connected Care, LLC (ACO ID: A2419), participating under the MSSP model.

Brennan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,597 traditional Medicare patients, billed 4,004 HCPCS/CPT codes, and received $190,717 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 7,956 prescription claims across 1,062 beneficiaries totaling $1,508,891 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 3 records totaling $96. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $107,701 to $1,508,891. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,688	3,271	$163,204
2016	1,832	3,637	$209,571
2017	2,003	3,719	$186,888
2018	1,926	3,751	$192,631
2019	1,889	3,768	$195,277
2020	1,765	3,515	$184,922
2021	1,806	3,446	$185,480
2022	1,702	3,397	$169,662
2023	1,810	3,836	$176,756
2024	1,597	4,004	$190,717

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	202	1,615	$107,701
2016	301	2,490	$204,590
2017	381	2,816	$250,420
2018	469	3,453	$315,025
2019	557	4,249	$424,242
2020	649	5,166	$608,043
2021	741	7,042	$885,780
2022	902	7,707	$1,153,897
2023	936	6,119	$1,202,615
2024	1,062	7,956	$1,508,891

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	298	335	$122
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	338	344	$100
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	445	524	$11
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	201	220	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	814	1,238	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	583	31,696	$601,923
Jardiance	Empagliflozin	374	18,223	$348,901
Repatha Sureclick	Evolocumab	141	6,002	$115,087
Xarelto	Rivaroxaban	86	4,820	$85,077
Entresto	Sacubitril/Valsartan	58	3,185	$69,138

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$96	Boston Scientific Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for James Matthew Brennan, M.D.?

Tedicare shows public-source Medicare data for James Matthew Brennan, M.D. (NPI 1164689105), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Matthew Brennan, M.D. have ACO affiliation data?

James Matthew Brennan, M.D. is shown with ACO affiliation data for Duke Connected Care, LLC (MSSP, ACO ID A2419).

What billing organization is linked to James Matthew Brennan, M.D.?

James Matthew Brennan, M.D. is linked to DUKE HEALTH INTEGRATED PRACTICE, INC. (billing NPI 1205553369) in the available physician profile data.

Does James Matthew Brennan, M.D. have Open Payments data?

James Matthew Brennan, M.D. has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.